We have located links that may give you full text access.
Comparing Adolescent- and Adult-Onset Unexplained Cardiac Arrest - Results from the Dutch Idiopathic VF registry.
BACKGROUND: Current cohorts of idiopathic ventricular fibrillation (IVF) patients primarily include adult-onset patients. Underlying causes of a sudden cardiac arrest vary with age, therefore underlying causes and disease course may differ for adolescent-onset versus adult-onset patients.
OBJECTIVE: To compare adolescent-onset with adult-onset patients with an initially unexplained cause for VF.
METHODS: This study includes 39 patients with an index event ≤19 years (adolescent-onset) and 417 adult-onset patients from the Dutch Idiopathic VF registry. Event circumstances, clinical characteristics, a change in diagnosis, and arrhythmia recurrences were collected and compared between the two groups.
RESULTS: In total, 42 patients received an underlying diagnosis during follow-up (median of 7 [2 - 12] years), with a similar yield (15% for adolescent-onset vs. 9% for adult-onset, p=0.16). Among the remaining unexplained patients, adolescent-onset patients (n=33) had their index event at a median age of 17 [16 - 18] years, 72% were male. The youngest patient was 13 years. In comparison with adults (n=381), adolescent-onset patients more often had their index event during exercise (p<0.01). Adolescent-onset patients experienced more appropriate implantable cardioverter defibrillator (ICD) therapy (44% vs. 26%, p=0.03) during follow-up compared with adults. Inappropriate ICD therapy (26% vs. 17%, p=0.19), ICD complications (19% vs. 14%, p=0.41) and deaths (3% vs. 4%, p=1.00) did not significantly differ between adolescent-onset and adult-onset patients.
CONCLUSION: IVF may occur in adolescence. Adolescent-onset patients more often present during exercise compared with adults. Furthermore, they are more vulnerable for ventricular arrhythmias reflected by a higher incidence of appropriate ICD therapy.
OBJECTIVE: To compare adolescent-onset with adult-onset patients with an initially unexplained cause for VF.
METHODS: This study includes 39 patients with an index event ≤19 years (adolescent-onset) and 417 adult-onset patients from the Dutch Idiopathic VF registry. Event circumstances, clinical characteristics, a change in diagnosis, and arrhythmia recurrences were collected and compared between the two groups.
RESULTS: In total, 42 patients received an underlying diagnosis during follow-up (median of 7 [2 - 12] years), with a similar yield (15% for adolescent-onset vs. 9% for adult-onset, p=0.16). Among the remaining unexplained patients, adolescent-onset patients (n=33) had their index event at a median age of 17 [16 - 18] years, 72% were male. The youngest patient was 13 years. In comparison with adults (n=381), adolescent-onset patients more often had their index event during exercise (p<0.01). Adolescent-onset patients experienced more appropriate implantable cardioverter defibrillator (ICD) therapy (44% vs. 26%, p=0.03) during follow-up compared with adults. Inappropriate ICD therapy (26% vs. 17%, p=0.19), ICD complications (19% vs. 14%, p=0.41) and deaths (3% vs. 4%, p=1.00) did not significantly differ between adolescent-onset and adult-onset patients.
CONCLUSION: IVF may occur in adolescence. Adolescent-onset patients more often present during exercise compared with adults. Furthermore, they are more vulnerable for ventricular arrhythmias reflected by a higher incidence of appropriate ICD therapy.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app